Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis
Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis Vazquez-Martinez, M. A., Caprice, T., Amisha, F., Almaraz, A., Kim, J., Cao, B., Alomar, M. E., Khimani, F., Mishra, A., Nieder, M., Lazaryan, A., Ochoa-Bayona, J. L., Nishihori, T., Mirza, S., Faramand, R., Perez, L., Anasetti, C., Pidala, J. A., Bejanyan, N., Elmariah, H. ELSEVIER. 2024: 4871-4872View details for DOI 10.1182/blood-2024-208229
View details for Web of Science ID 001412523500028